{"entity":{"id":"nct07286695","kind":"trial","name":"Fruquintinib Combined With Trifluridine/Tipiracil Versus Bevacizumab Combined With Trifluridine/Tipiracil for Advanced Metastatic Colorectal Cancer","aka":[],"tldr":"A phase 2 trial in colorectal cancer, run by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, not yet recruiting.","summary":"Fruquintinib Combined With Trifluridine/Tipiracil Versus Bevacizumab Combined With Trifluridine/Tipiracil for Advanced Metastatic Colorectal Cancer is a phase 2, randomised interventional study registered as NCT07286695 by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, with a registry enrolment figure of 292 participants, started 2025-12-31 and due to reach its primary completion in 2029-12-31. Interventions recorded: Fruquintinib Combined With trifluridine/tipiracil; Bevacizumab combined with trifluridine/tipiracil. Conditions listed: Metastatic Colorectal Cancer (CRC); Colorectal Cancer. Primary outcome: Progression-free survival (PFS). Colorectal eligibility wording from the registry: \"* Diagnosed with advanced metastatic colorectal adenocarcinoma by histopathological examination;\". Sites: China. No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07286695","url":"https://clinicaltrials.gov/study/NCT07286695"}],"tags":["ctgov-ingest","colorectal-deep-dive"],"related":[],"cancers":["rectal-cancer","colon-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07286695","phase":"2","setting":"A Multicenter, Open-label, Randomized Controlled Study of Fruquintinib Combined With Trifluridine/Tipiracil Versus Bevacizumab Combined With Trifluridine/Tipiracil in the Treatment of Patients With Advanced Metastatic Colorectal Cancer Who Failed Standard Chemotherapy","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","enrolled":292,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07286695/","neighbours":{"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"},{"id":"rectal-cancer","kind":"cancer","name":"Rectal cancer","route":"/cancers/rectal-cancer/"}],"term":[{"id":"colorectal-trials-open-today","kind":"term","name":"Colorectal cancer trials open today (registry snapshot)","route":"/terms/colorectal-trials-open-today/"}]}}